Search Results

1-20 of 23 results for subject:Testing

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Deputy Prime Minister, if he will authorise drug testing of staff within his Department. - The Office of the Deputy Prime Minister currently has no plans to introduce drug testing of staff.

Asked by

Lord Pickles (Conservative)

Answering body

Office of the Deputy Prime Minister

Type

Written questions

Status

Answered

Date

15 July 2003

Reference

122136; 409 c298W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what assessment he has made of the health consequences of the sale of genetic testing kits to the public; what plans he has to regulate the sale of genetic testing kits; what assessment has been made of the voluntary system of regulation...

Asked by

Andrew Murrison (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

10 May 2002

Reference

385 c403-4W; 54203;54205;54204

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how much NHS spending there was in 2001-02 on serological screening and direct investigative testing for (a) HIV, (b) chlamydia and (c) related hepatitis due to drug abuse and usage.

Asked by

Liam Fox (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

18 April 2002

Reference

47874; 383 c1179W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many new liquid cytology units there have been since the publication of the NHS National Plan.

Asked by

Liam Fox (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

15 April 2002

Reference

47012; 383 c793W;383 c791W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what his policy is on (a) access to counselling and advice services, (b) procedures for gaining informed consent and (c) protection of personal genetic information where genetic testing is being undertaken. - Inc ref to House of Commons Select Committee on Science...

Asked by

Ian Gibson (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

18 March 2002

For answer on

15 April 2002

Answered on

15 April 2002

Dr. Gibson: To ask the Secretary of State for Health what his policy is on (a) access to counselling and advice services, (b) procedures for gaining informed consent and (c) protection of personal genetic information where genetic testing is being undertaken. [44759] Yvette Cooper: Patients may seek advice from their General Practitioner, other health care workers or NHS Direct. Specialist NHS services for genetics are concentrated in Regional Genetic Centres (RGCs), to which patients may be referred as appropriate. Those receiving genetic tests as part of NHS clinical genetic services normally receive counselling and advice before and, where appropriate, after testing. The Government response to the 3{rd} Report of the House of Commons Select Committee on Science and Technology 1994-5, stated that: `The Government agrees with the Committee.. that people who seek diagnosis of a genetic condition of late onset, i.e in adult life, should be given adequate information about the medical and social implications of the findings and offered sufficient counselling, in advance of any testing, and subsequently if the result of a test is positive'. The Secretary of State announced in January 2002 how part of the £30 million investment in genetics would be used to pump-prime additional capacity within existing genetics services. This will enable more people concerned about familial disease to receive advice, testing and counselling. Patients have a fundamental legal and ethical right to determine what happens to their own bodies. Valid consent to treatment is therefore central to all forms of healthcare, from providing personal care to undertaking major surgery. Patients may indicate consent non-verbally (for example by presenting their arm for their pulse to be taken), orally, or in writing. For the consent to be valid, the patient must: be competent to take the particular decision; have received sufficient information to take it; and not be acting under duress. The Department has issued guidance on consent, and this should be consulted for advice on the current law and good practice requirements in seeking consent. This includes what to do when a patient lacks the capacity to give consent to an intervention. The relevant documents are available at "www.doh.gov.uk/consent". Health professionals should also be aware of any guidance on consent issued by their own regulatory bodies. Genetic information, like most other patient information, is held in confidence by health professionals and is also subject to the requirements of Data Protection legislation. This means that, unless exceptional circumstances apply, individuals should be informed about how the information will be used and that the information should only be disclosed to a third party with the consent of the person to whom it refers. The Department published a national confidentiality strategy for the NHS "("Building the Information Core: Protecting & Using Patient Information: A Strategy for the NHS")" in December 2001. The development of systems and processes to record and respect patient preferences including objections to disclosures is a key element of the strategy. In addition, the Human Genetics Commission (HGC) has been considering issues associated with the storage, protection and use of personal genetic information and will be reporting to Ministers later this spring.

Date

15 April 2002

Reference

44759; 383 c783-4W;383 c781-2W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what the licensing and vetting procedures are for new genetic tests to be sold directly to the public; what mechanisms have been put into place to ensure that claims made by manufacturers of currently licensed genetic tests have scientific and medical validity;...

Asked by

Ian Gibson (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

15 April 2002

Reference

383 c782-3W;383 c780-1W; 44758;44762;44763

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has to introduce a uniform, standardised test for apolypoproteius. - (Holding answer 8 February 2002).

Asked by

Simon Burns (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

25 February 2002

Reference

24649; 380 c1028W;380 c1030W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what advice the Government received in March 2000 from the Committee on Safety of Medicines on the need for medical supervision of the supply of the morning-after pill to girls under 16; whether that advice has been superseded; and what action is...

Asked by

Andrew Turner (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

23 January 2002

Reference

378 c963-5W; 28207;28205;28212

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will announce a timetable for the national roll out of the 20 universal neonatal hearing screening pilots.

Asked by

Caroline Spelman (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

20 July 2001

Reference

5814; 372 c738W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if his Department will provide guidance to health service providers carrying out universal neo-natal hearing screening about the need to inform other statutory authorities about the detection of deafness. - Inc figure. (Holding answer 2 July 2001).

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 July 2001

Reference

1344; 371 c222W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, who will hold the annual budget for liquid based cytology consumables in England and Wales referred to in paragraph 14 of NICE's appraisal of liquid-based cytology.

Asked by

Sandra Gidley (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

26 June 2001

Reference

303; 370 c75-6W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what information his Department has given to (a) health authorities and (b) NHS trusts about plans to roll out the Universal Neonatal Hearing Screening pilot project; and what advice he has given about the timescale for preparing for the roll-out; what the...

Asked by

Christopher Chope (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

3 May 2001

Reference

367 c758W; 158647;158648

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what safeguards apply to ensure that people applying for insurance policies are not asked to reveal the results of tests for genetic conditions which have not had approval from the Genetics and Insurance Committee.

Asked by

Siobhain McDonagh (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 March 2001

Reference

148856; 364 c418-9W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, when universal neonatal hearing screening will be piloted; in which health authorities it will be piloted; and how long it will be piloted before the Government announces the timetable for the national implementation of UNHS. - Includes list. (Holding answer 5 March...

Asked by

Oliver Heald (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

6 March 2001

Reference

151925; 364 c189W;364 c189-90W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on the benefit of allowing insurance companies to have access to genetic information about individuals. (Holding answer 30 January 2001).

Asked by

Tony Lloyd (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

26 February 2001

Reference

147026; 363 c425-6W;363 c424-5W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will announce a timetable for universal neonatal hearing screening throughout England. - Includes figures.

Asked by

Lord Boswell of Aynho (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

9 January 2001

Reference

144051; 360 c537W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, for what reason Huntingdon's disease was selected as a condition which could be the subject of inquiry by insurance companies in deciding whether or not to offer insurance cover; and if he will make a statement.

Asked by

Gordon Prentice (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 November 2000

Reference

356 c564W; 136553

House

House of Commons

Dept of Health

Statement on how much his Department has invested in neo-natal hearing screening for each of the last five years; how much his Department plans to spend on (a) the launch and (b) the national rollout of the neo-natal hearing screening pilot project in each of the next three years; what...

Asked by

Caroline Spelman (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

13 July 2000

For answer on

25 July 2000

Answered on

25 July 2000

Mrs. Spelman: To ask the Secretary of State for Health (1) how much his Department has invested in neonatal hearing screening for each of the last five years; [131332] (2) how much his Department plans to spend on (a) the launch and (b) the national roll-out of the neonatal hearing screening pilot project in each of the next three years; [131333] (3) what cost to benefit analysis his Department has carried out of introducing universal neonatal hearing screening; [131334] (4) what studies his Department has carried out into the benefits of neonatal hearing screening; [131335] (5) what his Department's timetable is for the national roll-out of the neonatal hearing screening pilot project; when an announcement about a timetable will be made; and what factors will inform the timing of an announcement of the timetable; [131336] (6) if he will review the findings of the Colorado research project on neonatal hearing screening; [131337] (7) what consultations his Department has had with disability organisations of and for deaf and hard of hearing people about the launch of the neonatal hearing screening pilot project; [131338] (8) when his Department will establish an advisory group to advise on the launch and national roll-out of its pilot project for neonatal hearing screening; and when it will announce the composition of the group; [131339] (9) by what process his Department will establish (a) the criteria, (b) the selection procedure and (c) the timetable for the establishment of the 20 neonatal hearing screening pilot sites; [131340] (10) what discussions his Department has had with the Department for Education and Employment about developing the provision of language and education support for children from zero to two years in preparation for (a) the launch and (b) the national roll-out of its pilot project for neonatal hearing screening; [131341] (11) what discussions his Department (a) has had and (b) plans to have with (i) health authorities and NHS trusts, (ii) paediatric audiologists, (iii) ENT consultants, (iv) speech and language therapists and (v) cochlear implant centres about (A) the launch and (B) the national roll-out of the neonatal hearing screening pilot project. [131342] Yvette Cooper: Investment in neonatal hearing screening over the last five years is estimated to be in the region of £18 million per annum: that is £3 million per annum on targeted neonatal hearing screening and £15 million per annum on health visitors performing the infant distraction test. The United Kingdom National Screening Committee (NSC) has recommended that a universal neonatal hearing screening (UNHS) programme should replace the infant distraction test to screen for hearing impairment. This was based on a report by the health technology assessment programme `A critical review of the role of neonatal screening in the detection of congenital hearing impairment'. An expert group, which included representatives of professional groups, National Health Service bodies, voluntary organisations, Government Departments and other interested bodies, was convened by the NSC and undertook further detailed work on the benefits, cost-benefits and feasibility and service issues of developing a UNHS programme. The committee took existing and emerging research findings into account in making its recommendations. We have recently agreed to conduct a pilot programme to evaluate the optimum way in which this change in service delivery might be achieved. The pilot programme will run for 12 months at a cost of £750,000. The pilot will help us gain a better understanding of the operational implications of running a national programme, including its potential cost. Project and steering groups will be established shortly to oversee the development of the pilot programme. Key professional, voluntary, NHS and policy stakeholders will be appropriately involved. The Department will be writing to the NHS about participating in the pilot project and the timescales later in the autumn.

Date

25 July 2000

Reference

354 c497-8W; 131332;131333;131334;131335;131336;131337;131338;131339;131340;131341;131342

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will respond to the report published in 1999 by the Human Genetics Advisory Commission, The Implications of Genetic Testing for Employment. - Includes ref to letter sent to Human Genetic Commission. Copy in Library (Dep 00/1436).

Asked by

Jim Cunningham (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

24 July 2000

Reference

354 c408W;354 c408-9W; 132741

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, when he plans to make an announcement on the implementation of universal neonatal hearing screening following the recommendations by the National Screening Committee. - (Holding answer 6 April 2000).

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

7 April 2000

Reference

347 c617W; 117609

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher